BioStock: Saniona's take on AstronauTx's capital raise

Saniona’s partner AstronauTx has closed a USD 61 million Series A financing to create new treatments for Alzheimer's disease, attracting capital from several leading global venture investors. BioStock reached out to Thomas Feldthus, CEO of Saniona, for a comment.

Read the interview with Thomas Feldthus at biostock.se:

Saniona's take on AstronauTx's capital raise - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/